Anti‐PrP antibodies block PrP<sup>Sc</sup> replication in prion‐infected cell cultures by accelerating PrP<sup>C</sup> degradation
Véronique Perrier(Centre National de la Recherche Scientifique), Sylvain Lehmann(Université de Montpellier), Jérôme Solassol(Inserm), Yveline Frobert(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Jacques Grassi(Universidade Federal do Espírito Santo), Carole Crozet(Inserm), Chantal Mourton-Gilles
Cited by 118
Related Papers
Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay
|Analytical Chemistry|1985|707
Screening of 145 Anti-PrP Monoclonal Antibodies for Their Capacity to Inhibit PrPSc Replication in Infected Cells
|Journal of Biological Chemistry|2004|330
Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2.
|Journal of Biological Chemistry|1993|289
The mechanism of internalization of glycosylphosphatidylinositol‐anchored prion protein
|The EMBO Journal|2003|282
The Disintegrins ADAM10 and TACE Contribute to the Constitutive and Phorbol Ester-regulated Normal Cleavage of the Cellular Prion Protein
|Journal of Biological Chemistry|2001|281